5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid

C11H16N4O5S — CID 115596223

IUPAC5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid
SMILESO=C(O)c1cn[nH]c1S(=O)(=O)NCC(=O)N1CCCCC1
InChIInChI=1S/C11H16N4O5S/c16-9(15-4-2-1-3-5-15)7-13-21(19,20)10-8(11(17)18)6-12-14-10/h6,13H,1-5,7H2,(H,12,14)(H,17,18)
InChIKeyQOEIDWDZZZZPAX-UHFFFAOYSA-N
MW316.34 g/mol
LogP-0.60
Rot. Bonds5

About 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid

5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid (PubChem CID 115596223) has the molecular formula C11H16N4O5S and a molecular weight of 316.34 g/mol. Its IUPAC name is 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid.

Molecular Properties

Compound Name5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid
PubChem CID115596223
Molecular FormulaC11H16N4O5S
Molecular Weight316.34 g/mol
Exact Mass316.08
IUPAC Name5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid
SMILESO=C(O)c1cn[nH]c1S(=O)(=O)NCC(=O)N1CCCCC1
InChIInChI=1S/C11H16N4O5S/c16-9(15-4-2-1-3-5-15)7-13-21(19,20)10-8(11(17)18)6-12-14-10/h6,13H,1-5,7H2,(H,12,14)(H,17,18)
InChIKeyQOEIDWDZZZZPAX-UHFFFAOYSA-N
XLogP-0.60
TPSA132.46 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500316.34
LogP ≤ 5-0.60
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-[3-(trifluoromethyl)piperidin-1-yl]sulfonyl-1H-pyrazole-4-carboxylic acid
CID 60917879
5-[4-(trifluoromethyl)piperidin-1-yl]sulfonyl-1H-pyrazole-4-carboxylic acid
CID 65533858
ethyl 4-{[4-(ethoxycarbonyl)-1H-pyrazol-5-yl]sulfonyl}piperazine-1-carboxylate
CID 46297833
5-[(4'-Carbamoyl-1,4'-bipiperidyl-1'-yl)sulfonyl]-4-pyrazolecarboxylic acid
CID 71794413
5-((4-(tert-butoxycarbonyl)piperazin-1-yl)sulfonyl)-1H-pyrazole-4-carboxylic acid
CID 71794414
5-(4-ethylpiperidin-1-yl)sulfonyl-1H-pyrazole-4-carboxylic acid
CID 54876692
5-[2-(dimethylamino)propylsulfamoyl]-1H-pyrazole-4-carboxylic acid
CID 54912854
5-(4-methylpiperazin-1-yl)sulfonyl-1H-pyrazole-4-carboxylic acid
CID 54929559
5-(4-methylpiperidin-1-yl)sulfonyl-1H-pyrazole-4-carboxylic acid
CID 54929738
5-(2-methylpiperidin-1-yl)sulfonyl-1H-pyrazole-4-carboxylic acid
CID 54929834
5-(pentylsulfamoyl)-1H-pyrazole-4-carboxylic acid
CID 54933832
5-[ethyl(propyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid
CID 54933835

Frequently Asked Questions

What is the IUPAC name of 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid?
The IUPAC name of 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid (CID 115596223) is 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid.
What is the SMILES notation for 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid?
The canonical SMILES for 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid is O=C(O)c1cn[nH]c1S(=O)(=O)NCC(=O)N1CCCCC1.
What is the InChIKey of 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid?
The InChIKey is QOEIDWDZZZZPAX-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H16N4O5S/c16-9(15-4-2-1-3-5-15)7-13-21(19,20)10-8(11(17)18)6-12-14-10/h6,13H,1-5,7H2,(H,12,14)(H,17,18).
What are the key properties of 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid?
5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid has a molecular weight of 316.34 g/mol, XLogP of -0.60, 5 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(2-oxo-2-piperidin-1-ylethyl)sulfamoyl]-1H-pyrazole-4-carboxylic acid is sourced from PubChem (CID 115596223), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).